Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis

Digestive and Liver Disease

Volumn 39, Issue 3, 2007, Pages 262-266

  Sanchez Munoz D ^a   Castellano Megias V M ^a   Romero Gomez M ^a  

^a HOSPITAL UNIVERSITARIO DE VALME   (Spain)

Author keywords

Apoptosis; Autoimmune cholestasis; Bcl 2

Indexed keywords

ALPHA ACTIN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; MITOCHONDRION ANTIBODY; MONOCLONAL ANTIBODY; PROTEIN ANTIBODY; PROTEIN BCL 2; SMOOTH MUSCLE ANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CELL PROLIFERATION; CHOLESTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; GRANULOMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; MALE; PRIMARY BILIARY CIRRHOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STELLATE CELL;

ADULT; AGED; AUTOIMMUNE DISEASES; BILE DUCTS; CELL PROLIFERATION; CHOLESTASIS; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 33846673890     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.12.004     Document Type: Article

References (28)

1. Romero-Gomez M., Wichmann I., Crespo J., Pares A., Rodrigo L., Alvarez A., et al. Serum immunological profile in patients with chronic autoimmune cholestasis. Am J Gastroenterol 99 (2004) 2150-2157
2. Nishio A., Keeffe E.B., and Gershwin M.E. Immunopathogenesis of primary biliary cirrhosis. Sem Liver Dis 22 (2002) 291-302
3. Harada K., Ozaki S., Gershwin M.E., and Nakanuma Y. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis. Hepatology 26 (1997) 1399-1405
4. Macdonald P., Palmer J., Kirby J.A., and Jones D.E. Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex. Clin Exp Immunol 136 (2004) 559-567
5. Tinmouth J., Lee M., Wanless I.R., Tsui F.W., Inman R., and Heathcote E.J. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. Liver 22 (2002) 228-234
6. Odin J.A., Huebert R.C., Casciola-Rosen L., LaRusso N.F., and Rosen A. Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest 108 (2001) 223-232
7. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
8. Towbin H., Staehelin T., and Gordon J. Electrophoretic transfer of proteins from polyacrilamide gels to nitrocellulose sheets: procedure and some applications. Biotechnology 24 (1992) 145-149
9. Ludwig J., Dickson E.R., and McDonald G.S. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch 379 (1978) 103-112
10. Portmann B., Popper H., Neuberger J., and Williams R. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology 88 (1985) 1777-1790
11. Scheuer P.J. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13 (1991) 372-374
12. Liu H., and Pope R.M. The role of apoptosis in rheumatoid arthritis. Curr Opin Pharmacol 3 (2003) 317-322
13. Manganelli P., and Fietta P. Apoptosis and Sjogren syndrome. Semin Arthritis Rheum 33 (2003) 49-65
14. Yachida M., Kurokohchi K., Arima K., and Nishioka M. Increased bcl-2 expression in lymphocytes and its association with hepatocellular damage in patients with autoimmune hepatitis. Clin Exp Immunol 116 (1999) 140-145
15. Koga H., Sakisaka S., Ohishi M., Sata M., and Tanikawa K. Nuclear DNA fragmentation and expression of Bcl-2 in primary biliary cirrhosis. Hepatology 25 (1997) 1077-1084
16. Kuroki T., Seki S., Kawakita N., Nakatani K., Hisa T., Kitada T., et al. Expression of antigens related to apoptosis and cell proliferation in chronic nonsuppurative destructive cholangitis in primary biliary cirrhosis. Virchows Arch 429 (1996) 119-129
17. Deguchi A., Arima K., Masaki T., Yachida M., Nakai S., Ito T., et al. Enhanced expression of Bcl-2 in lymphocytes infiltrating into the liver of patients with primary biliary cirrhosis. Int J Mol Med 9 (2002) 571-577
18. Alvaro D., Invernizzi P., Onori P., Franchitto A., De Santis A., Crosignani A., et al. Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis. J Hepatol 41 (2004) 905-912
19. Graham A.M., Dollinger M.M., Howie S.E., and Harrison D.J. Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis. Eur J Gastroenterol Hepatol 10 (1998) 553-557
20. Tsukamoto H. Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin Exp Res 23 (1999) 911-916
21. Ohata M., Lin M., Satre M., and Tsukamoto H. Diminished retinoic acid signaling in hepatic stellate cells in cholestatic liver fibrosis. Am J Physiol 272 (1997) G589-G596
22. Lazaridis K.N., Strazzabosco M., and LaRusso N.F. The cholangiopathies: disorders of biliary epithelia. Gastroenterology 127 (2004) 1565-1577
23. Ramm G.A., Hoskins A.C., Greco S.A., Pereira T.N., and Lewindon P.J. Signals for hepatic figrogenesis in pediatric cholestatic liver disease: review and hypothesis. Comp Hepatol 3 Suppl. 1 (2004) S5
24. Clouston A.D., Powell E.E., Walsh M.J., Richardson M.M., Demetris A.J., and Jonsson J.R. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. Hepatology 41 (2005) 809-818
25. Kinnman N., Francoz C., Barbu V., Wendum D., Rey C., Hultcrantz R., et al. The myofibroblastic conversion of peribiliary fibrogenic cells distinct from hepatic stellate cells is stimulated by platelet-derived growth factor during liver fibrogenesis. Lab Invest 83 (2003) 163-173
26. Issa R., Williams E., Trim N., Kendall T., Arthur M.J., Reichen J., et al. Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 48 (2001) 548-557
27. Schnabl B., Purbeck C.A., Choi Y.H., Hagedorn C.H., and Brenner D. Replicative senescence of activated human hepatic stellate cells is accompanied by a pronounced inflammatory but less fibrogenic phenotype. Hepatology 37 (2003) 653-664
28. Koukoulis G.K., Shen J., Karademir S., Jensen D., and Williams J. Cholangiocytic apoptosis in chronic ductopenic rejection. Hum Pathol 32 (2001) 823-827